ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies in Europe. The project aims to create a tool for decision-makers to understand the cost and value of these technologies.

ASCERTAIN

Solidaris Vlaanderen is a health insurance fund that advises individuals on choosing a health fund based on their region and membership status.

Solidaris Vlaanderen

Mendelian provides early disease identification services for healthcare providers, focusing on rare diseases.

Mendelian

Ouraring is a health technology company that specializes in developing wearable devices designed to empower individuals with insights into their health and wellness. The company's flagship product is a smart ring that tracks various physiological signals and provides users with personalized health metrics.

Markku Koskela

Petteri Lahtela

Ouraring

ASCERTAIN addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies in Europe.

Metric
Company Name	ASCERTAIN	Solidaris Vlaanderen	Mendelian	Ouraring
Symbol
MSH ID	EU:ACCESS2MEDS	BE:SOLIDARIS-VLAANDEREN	CO:MENDELIAN	COM:OURARING
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Health Technology Assessment	Health Insurance	Medical Technology	Health Technology
Country	EU	BE	UK	FI
Stage	Venture Round
Employee Count			23	621
Website	access2meds.eu	solidaris-vlaanderen.be	mendelian.co	ouraring.com
LinkedIn			mendelian	oura
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	1.24K
Web Traffic Growth
Valuation
Raised Capital	7.38M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ACCE

EU:ACCESS2MEDS

ASCERTAIN

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue